chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Membranous nephropathy; This literature-non-study case was reported in a literature article and describes the occurrence of GLOMERULONEPHRITIS MEMBRANOUS (Membranous nephropathy) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   LITERATURE REFERENCE:     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GLOMERULONEPHRITIS MEMBRANOUS (Membranous nephropathy) (seriousness criterion medically significant). At the time of the report, GLOMERULONEPHRITIS MEMBRANOUS (Membranous nephropathy) outcome was unknown. Related      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered GLOMERULONEPHRITIS MEMBRANOUS (Membranous nephropathy) to be related.    Treatment and concomitant medications were not reported.  This is a literature non-study case with reference to concerning a 54-year-old male patient with no reported medical history, who experienced the unexpected serious event of Glomerulonephritis membranous. The events was medically significant, which occurred on an unknown  date after receiving the second dose of mRNA-1273 COVID 19 Vaccine. No treatment details were given. It was reported that the outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   This case was linked to MOD-2022-539890, MOD-2022-539891, MOD-2022-539892, MOD-2022-539893, MOD-2022-539894, MOD-2022-539895, MOD-2022-539896, MOD-2022-539897, MOD-2022-539898, MOD-2022-539899, MOD-2022-539900, MOD-2022-539901, MOD-2022-539885, MOD-2022-539903 (Patient Link).; Sender's Comments: This is a literature non-study case with reference to concerning a 54-year-old male patient with no reported medical history, who experienced the unexpected serious event of Glomerulonephritis membranous. The events was medically significant, which occurred on an unknown  date after receiving the second dose of mRNA-1273 COVID 19 Vaccine. No treatment details were given. It was reported that the outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Knot feeling in throat. Patient describe feeling short of breath onset 30 minutes after TD given Monitored Pt and 2 Tsp Benadryl liquid given. Discharged home in improved stable condition.
pt recvd vax & devel a vesicular rash;no further details were provided;
Information has been received on 13-APR-2018 from a lawyer and a male consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 28-FEB-2014, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route, at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. On or about 12-NOV-2014, the patient was treated by a physician for a blistering vesicular outbreak which was diagnosed with herpes zoster, or shingles. The patient has been prescribed gabapentin for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Patient said her arm felt fine for the first couple days. Then she noticed some swelling below the site of administration. It appeared lower than what I would expect for a localized reaction. She said it didn't hurt but it was noticeably inflamed, slightly raised, and pink/red. She had a routine doctor appointment today and the nurse saw it and told her to come back to the pharmacy.
Pt recvd 1st dose of vax 6MAR91 & 15 minutes p/vax pt devel flushing, difficulty breathing; w/in another 15 minutes pt exp inc BP 160/110 & ears burned; BP to 160/120 ten minutes later; Pt was given DPH by ER MD; pt recovered;
Received / shot 2 years ago / believes it was not shaken before administration; This case was reported by a consumer via call center representative and described the occurrence of inappropriate reconstitution technique in a female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the patient received Boostrix (intramuscular). On an unknown date, unknown after receiving Boostrix, the patient experienced inappropriate reconstitution technique. On an unknown date, the outcome of the inappropriate reconstitution technique was unknown.  Additional case details were reported as follows: The patient reported case for herself. The age at vaccination was not reported. In 2018, the patient received Boostrix shot 2 years before day of reporting and believes it was not shaken before administration, which led to inappropriate reconstitution technique.  The reporter did not consent to follow up.
Cellulitis - large area of local reaction - arm. Seen in ER 3 times. She saw me on 12/27 when it was resolving.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 25-SEP-2014 the patient was vaccinated with an expired dose of PNEUMOVAX 23 (dose, route, lot# and expiration date were not reported). No adverse effects were noted. Additional information has been requested.
Revaccination with different COVID-19 vaccine; Extra dose administered; Interchange of vaccine products; No adverse event; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine), EXTRA DOSE ADMINISTERED (Extra dose administered), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine), EXTRA DOSE ADMINISTERED (Extra dose administered), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and NO ADVERSE EVENT (No adverse event). At the time of the report, COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine), EXTRA DOSE ADMINISTERED (Extra dose administered), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment drugs were reported. Patient had 18 shots of Pfizer and Modera.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Description of events: Increased HR, c/o SOB, shakiness, c/o difficulty swallowing  after receiving vaccine Intervention:  cool towel behind neck, car seat reclined VS checked, 30min monitoring No noted respiratory distress. Pt stated, "this reaction is like when I get I.V dye but not as severe." 1425 BP 146/88  1455 BP 110/60 P 88
Patient was in lobby sitting on knees, reports nausea and felt like she was going to pass out.  B/P 82/48, pulse 64. Patient was placed in lab chair with legs elevated and provided juice. Patient recovered and was released to care of her mother. Upon release, patient's B/P was 102/62 which patient reports is her normal, pulse was 80.
Gallbladder removal - staple hemorrhoidectomy-ibs  diagnoses. Lost 40 lbs. loss of appetite. Can?t have a bowel movement anymore with out taking Linzess. Been in and out of dr office and hospital ER for last 4 months.
Information has been received from a physician concerning a female was vaccinated with a first dose of Gardasil.  Subsequently, the patient experienced tenderness, soreness and swelling at injection.  Unspecified medical attention was sought.  Subsequently, the patient recovered from tenderness at injection, soreness at injection and swelling at injection.  Additional information has been requested.
Patient complained of fluctuating tachycardia between 110-150BPM after waiting about 10 minutes after receiving vaccine. Patient skin was hot and moist to the touch. Facility RN escorted patient to ER where she was seen. More information is not available at this time.
Big chicken pox on stomach, overnight, draining, called brother send prescription of antibiotic. It ended up been 2 inches. Went to dr. office - drained it. Arm looked red and hard as a rock and it hurt.
Menorrhagia for 2 straight months leading to abnormal lab test with severe anemia and critically low RBC and hemoglobin levels. Elevated heart rate upon exertion. Needed 1 pint of blood for a transfusion and an iron IV
Rash and nausea with vomiting. Immunized 3/1/03.
One week after getting the Moderna vaccine I developed a small red mark under my left arm (this was the arm the vaccine was administered). 3 days later it developed into a very large , very painful lump under my left arm. (size approximately 1.4 X 0.8 x 0.9 cm ). I saw my PCP who set up an apt for an ultrasound. Ultrasound completed and appears that this is a skin infection with an abscess developing. Im now on antibiotics and have an upcoming apt with a surgeon. I am 26 days out from receiving the vaccine and the lump has not gone down in size and is still painful. I am postponing my 2nd moderna vaccine due to this possible adverse reaction.
This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a adolescent female patient who received HPV vaccine. On an unknown date, the patient received HPV vaccine. On an unknown date, an unknown time after receiving HPV vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to HPV vaccine. Additional details were provided as follows: The age at vaccination was not reported. School nurse reported that the patient had returned to her office for complaining. The dose of HPV vaccine was administered in her left arm. Her left arm was little sore where the patient received HPV vaccine, but negligible compared to her right arm. This case has been linked to case US2017029654, for the same patient.
Encephalitis/meningitis (sore throat, vomiting, neck pain)  Patient recently returned from trip where traveled from 6/27/19 to 7/5/19. She received YF vaccine on 6/13/2019 (only vaccine that day)
This spontaneous report was received from a medical assistant referring to multiple unspecified patients of unknown age. Their pertinent medical history and concurrent conditions were not provided. On an unknown dates, the patients were vaccinated with doses of ROTATEQ, orally, lot # L027076, expiration date: 25-MAY-2017 (anatomical location and doses number were not reported) that were improperly stored. Information regarding concomitant therapy was not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
was observed post Covid-19 immunization for approximately 1 hr and 45min. Patient complained of being hungry stated she had not eaten all day around.  was given water and crackers, said she was feeling better but during further assessment she said she felt dizzy and light headed. Blood pressure right arm 160/103 hr 75. No complaints of chest pain or shortness of breath. She was talkative through out episode. Next BP was 184/91 HR 75. needed to go to the ladies room ambulated to rest room with nurse in attendance. No notable issue with gait.  The patient stated that she was feeling better but the blood pressures where elevated. Decided to ask EMT to do a manuel BP in the right  arm BP 160/82. Even though  was verbal, her responses where vague. One minute she felt fine then she was dizzy. was encouraged to call someone, but she felt she might be able to make it. There was a concern with her driving her self home.  EMT performed a cognitive test she stated the wrong year and did not know who the president was when asked in two separate assessments. They also performed a neuro assessment which was uneventful. EMT tried to contact sons but were unable too and patient could not find her phone where we could call a neighbor.  EMT suggested that she should go to the ED to be evaluated to be on the safe side and she agreed.
My sister and brother-in-law both contracted COVID-19 after receiving their first dose of the Pfizer Covid-19 Vaccine; My sister and brother-in-law both contracted COVID-19 after receiving their first dose of the Pfizer Covid-19 Vaccine; This is a spontaneous report from a contactable consumer. This consumer reported for a patient (reporter's brother-in-law).  A 91-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 26Jan2021 (age at vaccination: 91 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter reported that my sister and brother-in-law both contracted COVID-19 after receiving their first dose of the Pfizer Covid-19 Vaccine on an unspecified date in 2021. The reporter would like to know if they could receive their second dose or would they need to repeat the series. The patient underwent lab test and procedure included Covid 19 with positive result on an unspecified date in 2021. There was a Product Complaint. Description of Product Complaint included Pfizer Covid 19 vaccine: Tested positive after getting first dose of Pfizer Covid 19 vaccine. Product strength and count size dispensed: Is a sample of the product available to be returned, if requested (Y/N): Packaging sealed and intact? Outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt has reported having a sore arm since the date of the vaccine. She said that the muscle pain extends from the top of her arm to her elbow. There is no swelling or tingling or numbness. She has not experienced redness or a reaction at the injection site. It is a dull ache in her arm that has not gone away.
Information has been received from a physician and a licensed practical nurse concerning a 13 year old female with no drug allergies and no medical history, who on 06-OCT-2006 was vaccinated intramuscularly into the right deltoid with a 0.5mL first dose of Gardasil. On 13-AUG-2007 the patient was vaccinated with a second dose of Gardasil. There was no concomitant medication. On 25-AUG-2007 the patient experienced pain that started in both arms, progressed to her legs, and then to her whole body. On 26-AUG-2007 the patient went to the emergency room. She was treated with over the counter analgesics and released. On 29-AUG-2007 she was seen at the office because the pain had not stopped. The patient had since been hospitalized, and the symptoms have continued to the present. It was also reported by the nurse that the patient received the injection in her left arm and that the left arm was more painful then the right arm. Laboratory diagnostics were performed but details were not available. At the time of the report the patient had not recovered. No product quality complaint was involved. The reporting physician considered pain that started in both arms, progressed to her legs and her whole body as an other important medical event. Additional information has been requested.
Rash on her face and scalp; had no energy; This is a spontaneous report received from a contactable Nurse. A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history included diverticulitis reported as she was taking two antibiotics for 2 weeks for a diagnosis of diverticulitis. Patient states she stopped antibiotics last week. Concomitant medications included Montelukast sodium (SINGULAIR, 10 Mg Tablet), Metoprolol succinate, Pregabalin (LYRICA 100 Mg Capsule), Levothyroxine sodium (SYNTHROID, 50 Mcg Tablet), Cyclobenzaprine HCl 10 Mg Tablet, Diltiazem HCl 30 Mg Tablet, Duloxetine HCl 20 Mg Capsule, Omeprazole (PROTONIX 20 Mg Tablet), Cetirizine hydrochloride (ZYRTEC 10 Mg Capsule), Meclizine HCl 12.5 Mg Tablet, Fluticasone propionate (FLONASE ALLERGY RELIEF), Salbutamol sulfate (ALBUTEROL SULFATE HFA), Diclofenac sodium (VOLTAREN, 1 % Gel (Gram)), Fluticasone propionate (FLOVENT), Calcium carbonate (TUMS CHEWABLES 200(500) Mg Tab Chew), Betacarotene, Bioflavonoids nos, Biotin, Calcium ascorbate, Calcium pantothenate, Calcium phosphate, Choline bitartrate, Chromic chloride, Colecalciferol, Copper sulfate, Cyanocobalamin, Folic acid, Hesperidin, Inositol, Iron amino acid chelate, Lycopene, Lysine hydrochloride, magnesium oxide, Manganese sulfate, Molybdenum trioxide, Nicotinamide, Phytomenadione, Potassium iodide, Potassium sulfate, Pyridoxine hydrochloride, Retinol acetate, Riboflavin, Selenomethionine, Silicon dioxide, Colloidal Sodium borate decahydrate, Thiamine mononitrate, Tocopheryl acid succinate, Ubidecarenone, Zinc oxide (MULTIVITAMIN and MINERAL Capsule), Vitamin B12 5000 Mcg Tab Rapdis, Dr, Flovent Diskus 250 Mcg Blst W/Dev. It was reported that, the information about pregnancy was unknown.  On an unspecified date, the patient experienced rash on her face and scalp and had no energy. It was stated that, patient did not receive any instructions from her MD to hold Xeljanz to receive the vaccines. MD was aware. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation and experienced another rash and feels extreme exhaustion. The outcome of the event was not recovered.    No follow-up attempts are needed. Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021371887 same patient/ drug, different dose/ event
Patient developed a fever that night and it continued until the next day. Redness at injection site. I gave ibuprofen and acetaminophen staggered until normal temp. I was told he was getting a different type of immunization on 7/24/14 so it would not be the same reaction, but it was worse.
Lost use of right leg for matter of seconds with no warning. Went to ER. Did MRI and blood work.  Found nothing wrong.  Sent home.  The use of my leg came back in less than 1 minute.  Nothing else was done.  two months later I experienced muscle weakness in my lower right leg.  This time I could feel it coming on.  lost control again for less than a minute.  This muscle weakness has been on and off for the last week.  I have another MRI scheduled in a few days.
Received Pfizer 2nd dose in left arm on Aug 26, 2021.  on  Aug 28th  began to feel pain in center of left armpit down to just above left breast. Felt like a lump.  Then lymph node swelling, with surrounding tissue feeling like it was filled with water- sore to the touch.  Swelling and pain went down 48 hours after.
On 2/23/99, pt found out was preg;pt started spotting therefore seen by OB/GYN & they did a 48hr comparison & blood & results were not progressing as it should for preg;had two ultrasounds;MD confirmed spontaneous abortion;
i see stacked cells and dangers possibility of blood clotting; Feeling deathly ill; Cellularly my body having difficult time communicating to my brain; Inflammation of many internal organs; physical internal pain; i am deeply intuitively feeling that this is spiritual warfare; This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm right on 07Aug2021 14:00 (Lot Number: EW0217) at age of 28-year-old as single dose for covid-19 immunisation. The patient medical history was not reported.    The patient's concomitant medications were not reported. No other vaccine in four weeks.The patient experienced Its a poison to my body, Feeling deathly ill, Cellularly my body having difficult time communicating to my brain., Inflammation of many internal organs never felt this way ever in my life. After conducting microscopic research with microscope I see stacked cells and dangers possibility of blood clotting. As a spiritual being who communicates with divine entities, This is 100% the work of the devil. Not only am I receiving physical internal pain but I am deeply intuitively feeling that this is spiritual warfare. Adverse event start date was 15Aug2021 at time of 14:00. AE resulted in: Life threatening illness (immediate risk of death from the event). No treatment received. No covid prior vaccination. No covid tested post vaccination. The outcome of events was not recovered.  No follow up attempts are possible. No further information is expected.
Syncope, initial BP 220/126 (pulse 120). F/u BP 163/101 (pulse 74).
This spontaneous report was received from a physician assistant student referring to a patient of unknown age and gender. The patients' concurrent conditions, concomitant therapy, medical history and historical drugs were not reported. On 13-FEB-2018, the patient was vaccinated with expired PNEUMOVAX 23, intramuscular, expiry date: 23-AUG-2017 (strength, dose, frequency, lot # were not reported) for prophylaxis (expired product administered). No adverse effects were reported. No product quality compliant was reported.